CD8A and cancer: showed that CD8+FOXP3+ T cells are immunosuppressive, but, their inhibitor function could be altered using Toll‐Like Receptor (TLR)‐8 signaling40, 45 suggesting this could be utilized by immunotherapeutic strategies in cancer.40, 45